Alithea Genomics

About Alithea Genomics

Alithea Genomics specializes in RNA sequencing at scale, combining high throughput with high content for gene expression studies. Their mission is to enable drug screening, biomarker discovery, fundamental research, and crop science through innovative, cost-effective, and extraction-free transcriptomic solutions.

Products & Services

Mercurius™ DRUG-seq Kits and Services:Massively multiplexed, extraction-free kits and services for full-transcriptome profiling, ideal for large-scale compound screening.

Mercurius™ Spheroid DRUG-seq Kits:Extraction-free library preparation kits for spheroids, available in early access.

Mercurius™ Single-cell FLASH-seq Kits and Services:Ultra-sensitive, rapid, plate-based kits and services for high-resolution single-cell analysis.

Mercurius™ BRB-seq Kits and Services:Cost-effective, massively multiplexed 3' mRNA-seq kits and services for gene expression studies across various sample types like tissue, plant, and blood.

Mercurius™ Organoid DRUG-seq Service:Extraction-free RNA sequencing service for organoids.

Mercurius™ FFPE-seq Service:RNA sequencing service for degraded RNA samples from FFPE tissues.

Mercurius™ Accessories:Includes UDI expansion modules and lysis modules for DRUG-seq and spheroid applications.

Specialties

RNA Sequencing Transcriptomics Drug Screening Biomarker Discovery Single-cell Analysis Gene Expression Studies Crop Science

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed Financing Extension T: - FT: Seed Financing Extension	A: 3200000 MR: - FA: CHF 2.8 million FAN: 3200000	D: 2024-03-14 FD: 2024-03-14	2 investors

Seed Financing Extension Latest

2024-03-14

$3.2M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Andrea Hadjikyriacou

R

Riccardo Dainese

CEO and Co-founder

LinkedIn (Pro only)

D

Daniel Alpern

CTO and co-founder

LinkedIn (Pro only)

B

Bart Deplancke

Scientific Advisor and co-founder

F

Frederik Decouttere

Chairman of the Board

J

Jan Van den Berghe

Board member

View 6 more team members with Pro

Unlock Full Team Directory

Recent News